
|Articles|October 15, 2003
Spreading agent approval sought for hyaluronidase
Irvine, CA-ISTA Pharmaceuticals is seeking FDA approval to use hyaluronidase (Vitrase) as a spreading agent to facilitate the dispersion and absorption of other drugs.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement




























